**Core Concept**
The patient's presentation of bony pain, anemia (Hb -6 gm/dL), and a high ESR (140) suggests a diagnosis of multiple myeloma. Chromosomal abnormalities play a crucial role in the pathogenesis and prognosis of this disease. Specific chromosomal translocations can influence the prognosis and treatment outcome.

**Why the Correct Answer is Right**
The correct answer involves a specific chromosomal translocation that is associated with a favorable prognosis in multiple myeloma. The patient's peripheral smear likely shows plasmacytosis, which is characteristic of multiple myeloma. The presence of a t(11;14) translocation involving the IgH locus on chromosome 14 and the CCND1 gene on chromosome 11 is a common finding in multiple myeloma. This translocation leads to the overexpression of cyclin D1, which contributes to the proliferation of malignant plasma cells. However, t(11;14) is generally associated with a more indolent disease course and a better prognosis compared to other chromosomal abnormalities.

**Why Each Wrong Option is Incorrect**
**Option A:** **t(4;14)** is associated with a poor prognosis due to the presence of the MMSET gene, which contributes to the aggressive behavior of malignant plasma cells.
**Option B:** **t(14;16)** is also associated with a poor prognosis, as it involves the MAF gene, leading to the overexpression of a transcription factor that promotes the proliferation of malignant plasma cells.
**Option C:** **Deletion of 13q** is a common finding in multiple myeloma and is associated with a poor prognosis due to the loss of the RB1 tumor suppressor gene, leading to uncontrolled cell growth.

**Clinical Pearl / High-Yield Fact**
In multiple myeloma, the presence of a t(11;14) translocation is often associated with a more indolent disease course and a better prognosis. This can guide treatment decisions and inform discussions with patients regarding their prognosis.

**Correct Answer:** C. Deletion of 13q is associated with a poor prognosis in multiple myeloma.